After having shown, to our knowledge for the first time, that TF is expressed by CD133+ CSC in breast, lung and ovarian cancer [35], we showed that fVII-tPDT could effectively eradicate CSC by the induction of apoptosis and necrosis (Figure 4). This evidence concerns the gene PROM1 and ovarian cancer.